Guys, let’s be real here, that “I’m good” act isn’t fooling anybody. You have low energy. Low focus. Low drive. Your vitality is vital. Go get your testosterone checked.
https://t.co/Fv4jvkkISO
#MensHealthMonth#LowT#Vitality
FDA has approved Rextovy, a 4mg naloxone hydrochloride nasal spray, as an over-the-counter drug for the emergency treatment of opioid overdose.
This action aligns with the Great American Recovery Initiative, a federal effort to tackle addiction & substance use disorder through prevention, treatment, and long-term recovery.
If you have, or are considering purchasing, a SNOO Smart Sleeper, please be aware that the manufacturer has been selling new sleep sack sizes (X-Small and X-Large) and hospital SNOO bassinet bundles without first undergoing FDA review and obtaining FDA authorization.
The FDA strongly cautions patients, caregivers and health care providers that the X-Small and X-Large sleep sacks, and the SNOO Hospital Bundle, have not been evaluated for safety and effectiveness by the FDA and pose increased risks as described in the Warning Letter. The FDA also cautions that stains, soiling and unsanitary conditions have been reported on refurbished SNOOs distributed to customers, which may pose risk of infection. The FDA also cautions that mold has been reported on SNOO Smart Sleeper mattresses and/or mattress covers. Users should report any problems with SNOO products through the MedWatch Voluntary Reporting Form.
https://t.co/N75wsXjqmj
https://t.co/N7k00h15IE
FDA, in collaboration with federal and state partners, is investigating a multistate outbreak of three confirmed or suspected infant botulism illnesses.
https://t.co/IKcdmKju0u
Do not use any Nara Organics Whole Milk Organic Powdered Infant Formula.
NEWS: FDA cleared for marketing the first over-the-counter (OTC) continuous glucose monitor (CGM) for children. Dexcom Inc.’s Stelo Glucose Biosensor System is an integrated CGM (iCGM) indicated for people two years of age and older who do not use insulin.
The milestone is a powerful example of how real-world evidence (RWE) is informing regulatory decisions and supporting innovation – and it reflects our unwavering commitment to developing gold-standard science that protects the public health.
NEWS: The @US_FDA has issued an Emergency Use Authorization for generic Nitenpyram Tablets for the treatment of New World screwworm (NWS) infestations (myiasis) in dogs, puppies, cats, and kittens that weigh at least two pounds and are at least four weeks old.
We are working across the federal government to help ensure your pets are protected from screwworm.
Read the full release below:
https://t.co/8LPcsOoAmz
💊 To date, the FDA has approved 87 #Biosimilars—safe and effective options for many chronic conditions—highlighting continued growth in the biosimilars market. 📈
Learn more: https://t.co/1qiS054G1K.
Today, the FDA issued an emergency use authorization (EUA) for generic nitenpyram tablets, the first generic drug to receive an EUA for the treatment of New World screwworm (NWS) and the first over-the-counter product to treat NWS in dogs, puppies, cats, and kittens. https://t.co/1BouVUEnXB @Screwworm_RR
Burnout, depression, stress, anxiety - that stuff is REAL! Guys there is no need to suffer in silence like it’s a badge of honor. Do the right thing and take care of your mind the same way you take care of everything and everyone depending on you.
https://t.co/NLXAf4ohPK
#MensHealthMonth #MensMentalHealth
FDA is extending the comment period for the Request for Information on Drug Repurposing for Unmet Medical Needs by 30 days — now open until July 11, 2026! https://t.co/HEI7jGG6Km
Plus, join us for a hybrid public workshop on drug repurposing on August 5 that will cover public docket comments & approaches for prioritizing and selecting repurposing candidates. Stay tuned for registration details. https://t.co/RrbxhUjkzn
FDA is calling on patients, clinicians, and researchers to help identify drugs that could be repurposed to treat chronic and rare diseases and help address other unmet medical needs. Share your ideas to help advance new treatment options. https://t.co/qQPCrOfZwV
#Biosimilars are safe, effective alternatives to biologic medicines that help expand treatment options for chronic conditions like diabetes, arthritis, heart disease, and prostate cancer.
Learn more this #MensHealthMonth.
https://t.co/1qiS054G1K
The first new sunscreen active ingredient in 20 years! As the temperatures heat up this summer, FDA is happy to announce expanded options for consumers. Learn more: https://t.co/01tLN5fyiU
FDA continues to strengthen domestic manufacturing, enhance post-market surveillance, and accelerate generic drug reviews to ensure all Americans have access to safe, affordable medications. In our latest FDA Voices blog, learn how our generic drug program is advancing quality, access, and supply chain resilience. https://t.co/9TZyA3d5IW
Real men get checked. Prostate cancer doesn’t care how young you are, how tough you may feel, or how hard you grind. It will attack any man at any time. Get screened.
https://t.co/bsjUsSxAso
#MensHealthMonth#ProstateCancerPrevention
With the arrival of New World screwworm in the U.S., veterinarians have questions, and the FDA is here to help. @FDAanimalhealth has published a Dear Veterinarian Letter to help vets identify drugs conditionally approved + authorized for NWS and to explain vet legal responsibilities when prescribing drugs for NWS.
https://t.co/Q24z2FtwNU